One-on-One with Beghou Consulting’s Beth Beghou and Adrienne Lovink

Of course, we’ve built on that central tenet by launching our own proprietary technology as well. And while I’m pleased with how we’ve changed and evolved over the years, I’m most proud of what’s stayed the same – our culture. From day one, we have been laser-focused on building and nurturing a special environment that allows our immensely talented team to learn and grow as part of a commitment to sustained excellence and client success. It’s why we’ve had consultants who joined us right out of college still be part of the team decades later. That kind of continuity and commitment is rare.

Consulting: Your early embrace of data was certainly prescient. What are some of the data-driven market trends or pressures in the life sciences industry over the last five years that have changed how you engage with clients?

Beth: The popular mantra that the “only constant is change” has certainly been proven true in life sciences. The market is advancing at what seems like light speed, constantly shifting and growing in response to new technologies, macroeconomic conditions, regulatory requirements, and patient demands.

One big change has been an increasing emphasis on personalized medicine and targeted therapies for specific patient populations. This shift away from blockbuster drug launches and towards smaller disease communities while making smarter use of resources demands a more data-driven and tailored commercialization strategy.

 That’s especially true of the new wave of “one-and-done” curative therapies. With price tags reaching into the millions, reimbursement is more than just proving safety and efficacy. Insurers need drugmakers to show their product exceeds the standard of care and offsets real-world health costs for covered members. We engage with clients to meet this rising demand for payer insights.

Our clients are also integrating new technologies and strategies to enable more operational efficiency. And, of course, patients and healthcare professionals have begun to expect more transparency and custom support as part of these new therapies.

Throughout all this, we’ve maintained our well-earned reputation for balancing innovation and pragmatism. We grow alongside our clients by making sure our inputs are actionable and will actually move their bottom line. Innovation without traction and impact means they’re just spinning their wheels.

Consulting: Adrienne - looking ahead then, what do the next five years look like in the life sciences industry? What will clients expect from Beghou and how will you maintain or expand your position within the market? 

Looking ahead, I think a combination of regulatory and economic factors, expiring patents, and pricing pressures will mean the industry has to perform in the face of greater headwinds and uncertainty. But that also creates an opening for exciting new possibilities. Companies that are better at leveraging data and technology while nailing operations and commercial execution will be able to leapfrog their competition. It’s going to be an invigorating and exciting time, for which I think Beghou is ideally suited.

We have a well-deserved reputation for agility and maximizing opportunity capture, and that’s only going to grow stronger as companies continue to tap us to help them do more with less. We are also well-positioned to assist clients in a time of accelerated adoption of AI and digital transformation – from both a development and commercialization perspective. And I am eager to expand our work as a learning fly wheel connecting both big and small pharma and biotech companies so they can learn from one another.

In general, in this industry, especially as it relates to data and analytics, I’ve learned it’s easier to be wrong than right unless you really know what you’re doing. And Beghou has proven it knows what it’s doing. So, I’m excited to lean into this next phase of growth for our company and share that advantage with the market.

Consulting: Tell us about the process and strategy behind the decision to hand over the reins to Adrienne. How did you know the time was right and that she was the right person?

Beth: Having launched, grown, and led my own firm for the bulk of my career, I’ve learned to trust my instincts. And I was confident the time was right for a leadership change. Our foundation at Beghou is strong and the right people are in place to grow and expand our position in the market.

An enormous part of that calculation was Adrienne. I knew from the moment I met her that she shared my passion, purpose, and vision – and that she would fit in seamlessly with our culture. She’s been in life sciences leadership positions for more than 25 years and has an incredible track record in driving innovation and growth. Since she joined Beghou, she’s also been instrumental in shaping the evolution of our services and reinforcing the core values that define our organization. I trust her to own this next phase for the company and am excited to watch her take it forward.

I’ll continue to be deeply invested in Beghou’s success as a member of the Board of Directors, and I’ll serve as a close advisor to the leadership team as needed. I am so excited for the future on behalf of our teams and our clients.

Consulting: Adrienne, How did you learn of Beghou Consulting and what led you to join the team?

Adrienne: A mutual friend introduced me to Beth. Meeting casually over a glass of wine, I walked away deeply impressed by her vision for the company and commitment both to client excellence and her people. That was only reinforced after meeting some members of the team because it was clear she lives those values.

Now, having worked at Beghou for going on a year now, I’m even more blown away by the quality and diverse range of people Beth has assembled and where we’re headed as an organization. She has built a roster of incredibly talented, curious and motivated people who hail from different backgrounds with different ways of thinking and solving problems, but that all share a deep-seated passion for excellence in all that they do.

The life sciences space is moving fast in response to changing patient needs, new innovations, and market trends — and I earnestly believe there is no better team than Beghou to help companies navigate it successfully. Our combination of analytical minds, agility as an organization and powerful technology helps clients harness the full potential of their teams, data, and technology to maximize patient impact.

Consulting: You’ve both mentioned an emphasis on culture. What are Beghou’s core values and mission, and how have they guided your operational and strategic decisions within a an extremely dynamic and changing life sciences industry?

Beth: Our mission at Beghou Consulting is to drive impact and operational excellence in life sciences commercialization with analytical minds and innovative technology. But more than that, we’re committed partners for these companies and the people that work there. We care deeply about both, and we consider their problems our own - even when they’re in between roles or looking for their next adventure. This is more than just a job for us.

Similarly, our core values – we row together, we own every outcome, and we embrace the stretch (beyond our comfort zones) – are more than just words on a wall. They are lessons learned, refined, and passed along over the years that help us maintain our focus on the mission.

Consulting: What is the firm’s philosophy when it comes to hiring, and how have you balanced aggressive growth in line with your firm’s values and the industry’s needs?

Adrienne: Beth has embedded a company-wide emphasis on high standards, accountability, long-term partnerships, co-collaboration, and a drive for excellence — what we call the “Beghou Way.” That’s also core to our hiring philosophy, finding exceptional, analytical people who are aligned with those values. It’s foundational to ensuring we can cultivate strong relationships both with colleagues and clients.

It’s important to me that we also continue to offer the chance to do meaningful work that has a real-world impact. People join Beghou to work with advanced data analytics and cutting-edge technology but also to use their deep industry knowledge to help bring life-changing therapies to market. And they appreciate that we practice broad-based training, where everyone is exposed to all facets of the business and areas of expertise.

This focus on people and the systems to support them has been crucial to maintaining performance and satisfaction even as we’ve grown fast (headcount rose 35% in the past three years). It’s also why we were recertified as a “Great Place to Work” with 96% of our employees saying that when you join Beghou you are made to feel welcome. We’re so proud of that recognition and response!

Consulting: Adrienne, do you have insights based on your path to CEO for firms considering leadership transitions? And what are you focused on over the coming days and months as part of your personal agenda?

Adrienne: The most amazing part of my journey has been the time I had to work alongside Beth before assuming the role of CEO, learning the nuances of what she does every day and identifying opportunities to maintain the best elements of her approach while also making it uniquely my own. We deliberately built in a 90-day period where we could lead together as part of this transition so that handoffs both internally and externally were seamless. I think that went a long way towards giving everyone a comfort level while also building excitement for what’s next.

Looking ahead, I plan to accelerate our investments in both people and technology. The shift to doing more with less means that life sciences companies will need help developing new strategies, prioritizing their own investments, and pressure-testing innovative new technologies in service to patient outcomes. We call it “Commercialization That Works” - a practical and proven roadmap for doing all those things.

I’m also committed to both reinforcing the aspects of our culture that have helped make Beghou great and pushing us to grow alongside the changing needs of our clients so we can reach for even more. I am a firm believer in Beghou’s philosophy of treating client problems like our own because it forces a mindset shift that makes us all more invested in success. We also want to continue to build broad-based training protocols. We don’t want a handful of narrow specialists - we know that well-rounded teams benefit both clients and Beghou.

And from a growth perspective, I’m focused on a “Large and Loyal” approach that helps us move up-market to serve larger clients while continuing to invest in our small- and mid-size clients. That fits with our internal scaling strategy where we avoid tiering in our organization. There are no A or B teams at Beghou. Every client gets our best people.

Consulting: What are three characteristics or skills you think are most important for someone in your position in the life sciences space?

Adrienne:

• Let go of your ego. As a leader, it’s important that you be open to the best ideas, no matter where they come from.
• Be relentless in the quest for quality.
• Really listen and search for context. Nothing happens in isolation. Finding the “why” of a situation is the only way to see the full picture, which allows you to make a more informed decision.